{
    "output": [
        [
            "Novo Nordisk",
            "ORG",
            "Has",
            "caplacizumab",
            "PRODUCT"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Operate_In",
            "Haemophilia Market",
            "SECTOR"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Control",
            "Danish Group",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Impact",
            "Roche",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Has",
            "Lars Fruergaard Jorgensen",
            "PERSON"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Negative_Impact_On",
            "Key Diabetes Business",
            "SECTOR"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Raise",
            "Bid",
            "FIN_INSTRUMENT"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Participates_In",
            "Deal-making",
            "EVENT"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Invests_In",
            "Ablynx",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Specialize_In",
            "Nano-bodies",
            "CONCEPT"
        ],
        [
            "Ablynx",
            "ORG",
            "Partner",
            "Largest Pharmaceutical Companies",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Has",
            "Caplacizumab",
            "PRODUCT"
        ],
        [
            "Ablynx",
            "ORG",
            "Located_In",
            "Belgium",
            "GPE"
        ],
        [
            "Ablynx",
            "ORG",
            "Reject",
            "Novo Nordisk",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Has",
            "Share",
            "FIN_INSTRUMENT"
        ],
        [
            "Ablynx",
            "ORG",
            "Suspend",
            "Trading",
            "EVENT"
        ],
        [
            "Celgene",
            "ORG",
            "Clinch",
            "Deal",
            "EVENT"
        ],
        [
            "Celgene",
            "ORG",
            "Acquire",
            "Impact Biomedicines",
            "ORG"
        ],
        [
            "Celgene",
            "ORG",
            "Pay",
            "7 Billion Dollar",
            "FIN_INSTRUMENT"
        ],
        [
            "Takeda Pharmaceutical",
            "ORG",
            "Agree",
            "Buy",
            "EVENT"
        ],
        [
            "Takeda Pharmaceutical",
            "ORG",
            "Buy",
            "TiGenix",
            "ORG"
        ],
        [
            "Takeda Pharmaceutical",
            "ORG",
            "Pay",
            "630 Million Dollar",
            "FIN_INSTRUMENT"
        ],
        [
            "TiGenix",
            "ORG",
            "Located_In",
            "Belgium",
            "GPE"
        ],
        [
            "Global Blood Therapeutics",
            "ORG",
            "Discuss",
            "Potential Takeover",
            "EVENT"
        ],
        [
            "Global Blood Therapeutics",
            "ORG",
            "Focus",
            "Serious Blood Disorders",
            "SECTOR"
        ],
        [
            "Novo Nordisk",
            "ORG",
            "Regret",
            "Ablynx Decline",
            "EVENT"
        ],
        [
            "Belgium",
            "GPE",
            "Have",
            "Market Regulator",
            "ORG/REG"
        ],
        [
            "Belgium",
            "GPE",
            "Have",
            "Thriving Biotech Industry",
            "SECTOR"
        ],
        [
            "Belgium",
            "GPE",
            "Have",
            "Local Stock Exchange",
            "ORG"
        ],
        [
            "Belgium",
            "GPE",
            "Have",
            "Tax Breaks",
            "FIN_INSTRUMENT"
        ],
        [
            "Belgium",
            "GPE",
            "Have",
            "University Projects",
            "EVENT"
        ],
        [
            "Ablynx",
            "ORG",
            "Share_Price",
            "Almost Doubled",
            "ECON_INDICATOR"
        ],
        [
            "Ablynx",
            "ORG",
            "Products",
            "Undergoing Medical Trials",
            "EVENT"
        ],
        [
            "Ablynx",
            "ORG",
            "Products",
            "Target",
            "Diseases",
            "SECTOR"
        ],
        [
            "Euro",
            "FIN_INSTRUMENT",
            "Equal",
            "0.8322 Dollar",
            "ECON_INDICATOR"
        ]
    ]
}